An insulin-like growth factor 2-derived self-antigen inducing a regulatory cytokine profile after presentation to peripheral blood mononuclear cells from DQ8+ type 1 diabetic adolescents: Preliminary design of a thymus-based tolerogenic self-vaccination

Annals of the New York Academy of Sciences

Volumn 1037, Issue , 2004, Pages 59-64

  Geenen, Vincent ^a,b   Louis, C ^a   Martens, H ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Inst Pathol CHU B23 N   (Belgium)

Author keywords

IGF 2; Self antigens; Self vaccination; Thymus; Type 1 diabetes

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA DQ8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SOMATOMEDIN B;

ADOLESCENT; ANTIGEN PRESENTATION; AUTOIMMUNITY; CLINICAL ARTICLE; CONFERENCE PAPER; DIABETES MELLITUS; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; THYMUS;

EID: 14544305615     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1337.008     Document Type: Conference Paper

References (30)

1. GEENEN, V., F. ROBERT, H. MARTENS, et al. 1992. The thymic education of developing T cells in neuroendocrine self-principles. J. Endocrinol. Invest. 15: 621-629.
2. ROBERT, F., H. MARTENS, N. CORMANN, et al. 1992 The recognition of hypothalamoneurohypophysial functions by developing T cells. Dev. Immunol. 2: 131-140.
3. JOLICŒUR, C., D. HANAHAN & K.M. SMITH. 1994. T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous genes in the thymus. Proc. Natl. Acad. Sci. USA 91: 6707-6711.
4. GEENEN, V. 1995. La Communication Cryptocrine Intrathymique et la Tolérance Centrale au Soi Neuroendocrine. Professoral thesis, University of Liège.
5. MARTENS, H., B. GOXE & V. GEENEN. 1996. The thymic repertoire of neuroendocrine self-peptides: physiological implications in T-cell life and death. Immunol. Today 17: 312-319.
6. VANNESTE, Y., A. NTODOU-THOME, E. VANDERSMISSEN, et al. 1997. Identification of neurotensin-related peptides in human thymic epithelial cell membrane and relationship with major histocompatibility class I molecules. J. Neuroimmunol. 76: 161-166.
7. DERBINSKI, J., A. SCHULTE, B. KYEWSKY & L. KLEIN. 2001. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2: 1032-1039.
8. GEENEN, V., F. BRILOT, I. HANSENNE, et al. 2004. Thymus and T cells. In Encyclopedia of Neuroscience on CD-ROM, 3rd edit. G. Adelman & B.H. Smith, Eds. Elsevier. New York. ISBN 0-444-51432-5.
9. LIKE, A.A., E. KISLAUKIS, R.M. WILLIAMS & A.A. ROSSINI. 1982. Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB:W rat. Science 216: 644-646.
10. GEORGIOU, H.M. & T.E. MANDEL. 1995. Induction of insulitis in athymic (nude) mice. The effect of NOD thymus and pancreas transplantation. Diabetes 44: 49-59.
11. THOMAS-VASLIN, V., D. DAMOTTE, M. COLTEY, et al. 1997. Abnormal T-cell selection on NOD thymic epithelium is sufficient to induce autoimmune manifestations in C57BL/6 athymic nude mice. Proc. Natl. Acad. Sci. USA 94: 4598-4603.
12. KECHA-KAMOUN, O., I. ACHOUR, H. MARTENS, et al. 2001. Thymic expression of insulin-related genes in an animal model of type 1 diabetes. Diabetes/Metab. Res. Rev. 17: 146-152.
13. VAFIADIS, P., S.T. BENNETT, J.A. TODD, et al. 1997. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15: 289-292.
14. PUGLIESE, A., M. ZELLER, A. FERNANDEZ, JR., et al. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15: 293-297.
15. BRIMNES, M.K., T. JENSEN, T.N. JORGENSEN, et al. 2002. Low expression of insulin in the thymus of non-obese diabetic mice. J. Autoimmun. 19: 203-213.
16. CHENTOUFI, A.A. & C. POLYCHRONAKOS. 2002. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51: 1383-1390.
17. THEBAULT-BAUMONT, K., D. DUBOIS-LAFORGUE, P. KRIEF, et al. 2003. Acceleration of type 1 diabetes in proinsulin 2 deficient mice. J. Clin. Invest. 111: 851-857.
18. MORIYAMA, H., N. ABIRU, J. PARONEN, et al. 2003. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc. Natl. Acad. Sci. USA 100: 10376-10381.
19. KAUFMAN, D.L., M.C. CLARE-SALZLER, J. TIAN, et al. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72.
20. GOTTER, J., B. BRORS, M. HERGENHAHN & B. KYEWSKI. 2004. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J. Exp. Med. 199: 155-166.
21. DIEZ, J., Y. PARK, M. ZELLER, et al. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes 50: 895-900.
22. ERICSSON, A., V. GEENEN, F. ROBERT, et al. 1990. Expression of preprotachykinin-A and neuropeptide-Y messenger RNA in the thymus. Mol. Endocr. 4: 1211-1218.
23. EIZIRIK, D.L. & T. MANDRUP-PAULSEN. 2001. A choice of death: the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44: 2115-2133.
24. CHAILLOUS, L., H. LEFEVRE, C. THIVOLET, et al. 2000. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomized controlled trial. Diabetes Insulin Oral Group. Lancet 356: 545-549.
25. POZZILLI, P., D. PITOCCO, N. VISALLI, et al. 2000. No effect of oral insulin on residual beta-cell function in recent-onset type 1 diabetes. Diabetologia 43: 1000-1004.
26. DPT-TYPE 1 DIABETES STUDY GROUP. 2002. Effects of insulin in relatives of patients with type 1 diabetes. N. Engl. J. Med. 346: 1685-1691.
27. GOTTLIEB, P.A. & G.S. EISENBARTH. 2002. Insulin-specific tolerance in diabetes. Clin. Immunol. 102: 2-11.
28. ATKINSON, M.A. & E.H. LEITER. 1999. The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5: 601-604.
29. TARBELL, K.V., S. YAMAZAKI, K. OLSON, et al. 2004. CD25+ CD4+ T cells expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199: 1467-1477.
30. TANG, Q., K.J. HENRIKSEN, M. BI, et al. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465.